[go: up one dir, main page]

SK31695A3 - 5-vinyl-quinoline-carboxylic, 5-vinyl naphthyridine carboxylic, 5-ethyl-quinolone-carboxylic and 5-ethynyl-naphthyridon- -carboxylic acid, method of their production, medicines containing these matters and their using - Google Patents

5-vinyl-quinoline-carboxylic, 5-vinyl naphthyridine carboxylic, 5-ethyl-quinolone-carboxylic and 5-ethynyl-naphthyridon- -carboxylic acid, method of their production, medicines containing these matters and their using Download PDF

Info

Publication number
SK31695A3
SK31695A3 SK316-95A SK31695A SK31695A3 SK 31695 A3 SK31695 A3 SK 31695A3 SK 31695 A SK31695 A SK 31695A SK 31695 A3 SK31695 A3 SK 31695A3
Authority
SK
Slovakia
Prior art keywords
group
hydrogen atom
methyl
carbon atoms
vinyl
Prior art date
Application number
SK316-95A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas Himmler
Uwe Petersen
Klaus D Bremm
Rainer Endermann
Michael Stegemann
Heinz-Georg Wetzstein
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK31695A3 publication Critical patent/SK31695A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/762Organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/771Organic compounds containing hetero rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
SK316-95A 1994-03-11 1995-03-10 5-vinyl-quinoline-carboxylic, 5-vinyl naphthyridine carboxylic, 5-ethyl-quinolone-carboxylic and 5-ethynyl-naphthyridon- -carboxylic acid, method of their production, medicines containing these matters and their using SK31695A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4408212A DE4408212A1 (de) 1994-03-11 1994-03-11 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren

Publications (1)

Publication Number Publication Date
SK31695A3 true SK31695A3 (en) 1995-09-13

Family

ID=6512492

Family Applications (1)

Application Number Title Priority Date Filing Date
SK316-95A SK31695A3 (en) 1994-03-11 1995-03-10 5-vinyl-quinoline-carboxylic, 5-vinyl naphthyridine carboxylic, 5-ethyl-quinolone-carboxylic and 5-ethynyl-naphthyridon- -carboxylic acid, method of their production, medicines containing these matters and their using

Country Status (29)

Country Link
US (2) US5578604A (fr)
EP (1) EP0671391A1 (fr)
JP (1) JPH07285941A (fr)
KR (1) KR950032177A (fr)
CN (1) CN1111629A (fr)
AU (1) AU689189B2 (fr)
BG (1) BG62001B1 (fr)
CA (1) CA2144231A1 (fr)
CO (1) CO4340737A1 (fr)
CZ (1) CZ63895A3 (fr)
DE (1) DE4408212A1 (fr)
DZ (1) DZ1862A1 (fr)
EE (1) EE9500020A (fr)
FI (1) FI951101A7 (fr)
HR (1) HRP950077A2 (fr)
HU (1) HUT72071A (fr)
IL (1) IL112936A0 (fr)
LV (1) LV11469B (fr)
MA (1) MA23475A1 (fr)
NO (1) NO950936L (fr)
NZ (1) NZ270657A (fr)
PE (1) PE33895A1 (fr)
PL (1) PL307583A1 (fr)
RU (1) RU95103433A (fr)
SK (1) SK31695A3 (fr)
SV (1) SV1995000012A (fr)
TN (1) TNSN95017A1 (fr)
YU (1) YU15895A (fr)
ZA (1) ZA952008B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
DE19652219A1 (de) 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
US6984499B2 (en) * 1997-10-02 2006-01-10 Idexx Laboratories, Inc. Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility
CA2389553C (fr) * 1999-12-14 2010-06-22 Neurosearch A/S Heteroaryles-diazabicycloalcanes
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
EP1397365B1 (fr) * 2001-06-01 2005-02-16 NeuroSearch A/S Heteroaryl-diazabicyclo-alcanes a titre de modulateurs du snc
US7282344B2 (en) * 2001-06-06 2007-10-16 Neurosearch A/S Cation conducting GABAA receptors and their use
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
PT1666477E (pt) 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
CA2559809A1 (fr) 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Anticorps diriges contre le polypeptide humain hdgnr10, un recepteur de chimiokine (ccr5) couple a des proteines-g
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN103724262B (zh) * 2013-12-10 2016-05-18 广东省第二人民医院 一种氟喹诺酮银化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
NO885426L (no) * 1987-12-11 1989-06-12 Dainippon Pharmaceutical Co Kinolinderivater, samt fremgangsmaate ved fremstilling derav.
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
FI901201A7 (fi) * 1989-03-13 1990-09-14 Bristol Myers Squibb Co Antibakteeriset 5-substituoidut 1,4-dihydro-4-oksonaftyridiini-3-karboksylaattijohdannaiset ja niiden valmistus
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
ATE196135T1 (de) * 1991-05-28 2000-09-15 Daiichi Seiyaku Co Pyridoncarbonsäurederivate

Also Published As

Publication number Publication date
AU1364995A (en) 1995-09-21
LV11469B (en) 1996-12-20
KR950032177A (ko) 1995-12-20
BG62001B1 (bg) 1998-12-30
LV11469A (lv) 1996-08-20
HRP950077A2 (en) 1997-08-31
HU9500728D0 (en) 1995-04-28
FI951101A0 (fi) 1995-03-09
MA23475A1 (fr) 1995-10-01
FI951101L (fi) 1995-09-12
FI951101A7 (fi) 1995-09-12
CA2144231A1 (fr) 1995-09-12
CZ63895A3 (en) 1995-11-15
CN1111629A (zh) 1995-11-15
AU689189B2 (en) 1998-03-26
DZ1862A1 (fr) 2002-02-17
TNSN95017A1 (fr) 1996-02-06
US5659038A (en) 1997-08-19
BG99490A (en) 1996-01-31
PL307583A1 (en) 1995-09-18
DE4408212A1 (de) 1995-09-14
NO950936L (no) 1995-09-12
NZ270657A (en) 1997-01-29
JPH07285941A (ja) 1995-10-31
HUT72071A (en) 1996-03-28
YU15895A (sh) 1998-05-15
IL112936A0 (en) 1995-06-29
EE9500020A (et) 1995-12-15
NO950936D0 (no) 1995-03-10
ZA952008B (en) 1995-12-11
SV1995000012A (es) 1995-11-06
US5578604A (en) 1996-11-26
PE33895A1 (es) 1995-12-15
RU95103433A (ru) 1997-02-10
CO4340737A1 (es) 1996-07-30
EP0671391A1 (fr) 1995-09-13

Similar Documents

Publication Publication Date Title
IE81144B1 (en) 7-(1-Pyrrolidinyl)-3-quinolone-and -naphthyridone-carboxylic acid derivatives processes for their preparation and substituted mono- and bicyclic pyrrolidine derivatives as intermediate products for their preparation and antibacterial agents and feed additives containing them
SK31695A3 (en) 5-vinyl-quinoline-carboxylic, 5-vinyl naphthyridine carboxylic, 5-ethyl-quinolone-carboxylic and 5-ethynyl-naphthyridon- -carboxylic acid, method of their production, medicines containing these matters and their using
CZ192892A3 (en) Derivatives of 7-azaisoindolinyl-quinolonecarboxylic and naphthyridonecarboxylic acids
AU658901B2 (en) 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids
CZ396692A3 (en) Quinolonecarboxylic and naphthyridonecarboxylic acids derivatives
SK5394A3 (en) Quinolonecarboxilic acid naphtyridonecarboxilic acid derivatives
SK282274B6 (sk) Deriváty 7-izoindolinyl-chinolónu a 7-izoindolinyl-naftyridónu, spôsob ich výroby, medziprodukty tohto spôsobu, použitie a farmaceutický prostriedok
US5468742A (en) 8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
SK137194A3 (en) 1-(2-fluorinecyclopropyl)-quinoline-carboxylic) and 1-(2- -florinecyclopropyl)-naphthyridonecarboxylic acid derivatives, method of their producing and their using in medicines
JPH06192262A (ja) 7−(アミノメチル−オキサ−7−アザ−ビシクロ[3.3.0]オクト−7−イル)キノロンカルボン酸および7−(アミノメチル−オキサ−7−アザ−ビシクロ[3.3.0]オクト−7−イル)ナフチリドンカルボン酸誘導体
IE19970856A1 (en) 7-(1-Pyrrolidinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions